MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Palliative Care in Parkinson Disease

    A. Patterson, L. Almeida, M. Okun, I. Malaty (Gainesville, FL, USA)

    Objective: The objective of this study was to derive a baseline understanding of palliative care among the Parkinson disease (PD) patient population at a single…
  • 2017 International Congress

    Evolution of Globus Pallidus Internus (GPi) Deep Brain Stimulation Targeting Over 15 Years

    V. Holanda, L. Almeida, M. Okun, A. Patterson, W. Deeb, A. Shukla, K. Foote (Gainesville, FL, USA)

    Objective: To evaluate the evolution of GPi DBS targeting over time in a large single center cohort. Background: Deep brain stimulation (DBS) targeting the globus…
  • 2017 International Congress

    Pharmaeconomic study of the treatment of advanced Parkinson’s disease.

    F. VIVANCOS-MATELLANO, A. SANZ, J.U. MIRÓ, J. CADAVID, A. RUÍZ, N. SOLER (Madrid, Spain)

    Objective: Conduct a comparative pharmacoeconomic analysis of the use of  subcutaneous apomorphine infusion pump (SAIP),   continuous levodopa/carbidopa duodenal infusión (LDI) and deep brain stimulation (DBS). Background:…
  • 2017 International Congress

    Effect of deep brain stimulation of the subthalamic nucleus on cranial tremor in Parkinson’s disease

    L. Cameron, C. Kilbane, A. Shaikh (Cleveland, OH, USA)

    Objective: To analyze the effect of deep brain stimulation (DBS) of the subthalamic nucleus (STN) on cranial tremor in Parkinson’s disease (PD). Background: STN DBS…
  • 2017 International Congress

    Effects of deep brain stimulation on olfactory function in Parkinson’s disease

    R. Cury, M. Carvalho, M.g. Santos Ghilardi, A. Estevo, A. de Paiva, F. Lopez, A. Coutinho, M. Teixeira, E. Barbosa, E. Fonoff (São Paulo, Brazil)

    Objective: The aim of this prospective study was to assess the impact of deep brain stimulation (DBS) on olfactory function in Parkinson's disease (PD).  Background:…
  • 2017 International Congress

    Battery consumption and need for replacement in patients with Parkinson disease treated with interleaved deep brain stimulation

    L. Deuel, J. Pilitsis, A. Ramirez-Zamora (Albany, NY, USA)

    Objective: To evaluate battery life in patients managed with unilateral or bilateral subthalamic nucleus (STN) interleaved deep brain stimulation (DBS) Background: DBS is a common…
  • 2017 International Congress

    Long term tremor benefit from cyst formation as a complication of DBS surgery in a patient with Parkinson’s disease

    P. Morrison, I. Richard (Rochester, NY, USA)

    Objective: To describe the unexpected, beneficial effects of cyst formation as a complication of sub-thalamic nucleus (STN) deep brain stimulation (DBS) surgery in a patient…
  • 2017 International Congress

    Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study

    K. Anderson, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, H. Fernandez (Washington, DC, USA)

    Objective: To evaluate the long-term safety/tolerability of deutetrabenazine (DTB) in patients with tardive dyskinesia (TD). Week 54 open-label results are reported in this interim analysis.…
  • 2017 International Congress

    Motor dysfunctions in rats following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin

    R. Shukla, R. Gupta, A. Pant, V. Khanna (Lucknow, India)

    Objective: To investigate the targets associated in regulating motor functions following subsequent exposure to stress on the neurotoxicity of lambda-cyhalothrin in rats. Background: Stress that…
  • 2017 International Congress

    Hemidystonia Associated with Alexander Disease

    D. Vijayakumar, R. Lewis, G. Fuller, S. Dhar, K. Machol, L. Robak, J. Jankovic (Houston, TX, USA)

    Objective: To describe an uncommon movement disorder phenotype of Alexander disease (AD). Background: AD is a rare autosomal dominant disorder that causes progressive leukodystrophy, especially…
  • « Previous Page
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 155
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley